In this article, Stephen Yiu, discusses the performance of the Blue Whale fund as at the end of the first 6 months of 2022.
The first half of 2022 saw inflation fears of late 2021 come to a head. Accordingly, global equity markets saw increased volatility, with a mark down across the board.
Second quarter of 2022 review of the High Yield Market & the Liontrust High Yield Bond Fund & outlook for the High Yield Market in general.
In this article, Stephen Yiu, discusses the performance of the Blue Whale fund as at the end of April 2022 in light of the Ukraine crisis and inflation woes which have weighed heavily on markets this year.
First quarter of 2022 review of the High Yield Market & the Liontrust High Yield Bond Fund & outlook for the High Yield Market in general.
In this article, Blue Whale discusses the fact that global growth is not matching inflation rates (a key characteristic of stagflation) and therefore why it is important to look for those companies that are able to benefit from structural changes in the global economy that are not reliant on a buoyant macro-outlook.
Fourth quarter of 2021 review of the High Yield Market & the Liontrust High Yield Bond Fund & outlook for the High Yield Market in general.
In this article, Stephen Yiu gives a review of 2021 for the the Blue Whale Investment Funds ICAV.
In this article, Blue Whale discuss the current “demand-pull” inflation and the opportunities for investors in this unique inflationary environment.
Third quarter of 2021 review of the High Yield Market & the Liontrust High Yield Bond Fund & outlook for the High Yield Market in general.
In this article, Blue Whale offer a sneak peek into their research process to help investors understand what fund managers do in an otherwise opaque industry.
The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.
You are leaving medirect.com.mt
Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.
Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.
We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.
For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.